SY logo

So-Young International (SY)

Profile

Full Name

So-Young International Inc.

Ticker Symbol

SY

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

China

IPO

May 2, 2019

Indexes

Not included

Website

http://www.soyoung.com

Employees

1357

Key Details

Price

$0.76(-1.17%)

Market cap

Last Dividend

$0.03

TTM Dividend yield

3.48%

Annual revenue

$204.41M(-3.48% YoY)

Annual EPS

-$0.80(-2809.18% YoY)

PE ratio

-

Next earnings date

May 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.76
SY price is $0.76

30-Day Relative Volume

0.10
SY 30-day relative volume is 0.10

Price Performance

Price Most recent change

-1.17%
SY price was down -1.17% on Apr 11, 2025

Price YTD change

-8.31%
SY price is down -8.31% since January 1st

Price 1-year change

-33.25%
SY price is down -33.25% year-on-year

Price 3-year change

-59.3%
SY price is down -59.3% over the past 3 years

Price Range

Price All-time high

$22.80
SY price is currently -96.66% below its historical high of $22.80

Price 3-year low

$0.50
SY price is currently +52.20% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$76.83M
SY market capitalization is $76.83 million

Market cap 3-year change

-61.06%
SY market capitalization is down -61.06% over the past 3 years

Market cap All-time high

$2.08B
SY market capitalization is currently -96.31% below its historical high of $2.08 billion

Market cap sector rank

45.11%
SY market capitalization is higher than 45.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.3%
SY shares outstanding is down -1.3% year-on-year

Shares Outstanding 3-Year Change

-4.32%
SY shares outstanding is down -4.32% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.32
SY beta is 0.32

200-day SMA

$0.90
SY price is currently -15.67% below its 200-day simple moving average

50-day SMA

$0.91
SY price is currently -16.05% below its 50-day simple moving average

RSI

38.69
SY 14-day relative strength index is 38.69

Volume

0.10
SY 30-day relative volume is 0.10

ATR

$0.09
SY average true range is $0.09

10-day Historical Volatility

89.58%
SY 10-day historical volatility is 89.58%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.03
SY last dividend was $0.03 per share, with an ex-dividend date of April 8, 2025

Next Dividend

-
SY next dividend has not yet been announced

Dividend per share

Dividend per share

$0.06
SY annual dividend per share is $0.06

Dividend per share Sector Rank

2.33%
SY annual dividend per share is higher than 2.33% of companies in Healthcare sector

Dividend per share 1-Year Change

-
SY annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
SY annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

7.88%
SY annual dividend yield is 7.88%

Dividend yield Sector Rank

90.59%
SY annual dividend yield is higher than 90.59% of companies in Healthcare sector

Other

Payout ratio

-
SY annual payout ratio value is unknown

Dividends paid

-
SY annual dividends paid value is unknown

Free cash flow

-
SY annual free cash flow value is unknown

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$204.41M
SY annual revenue is $204.41 million

Revenue Analysts estimate

$1.55B
SY annual revenue is currently -86.85% lower than the consensus analysts' forecast

Revenue 1-year change

-3.48%
SY annual revenue is down -3.48% year-on-year

Revenue Sector rank

64.28%
SY annual revenue is higher than 64.28% of companies in Healthcare sector

EPS

EPS

-$0.80
SY annual earnings per share is -$0.80

EPS Analysts estimate

$0.68
SY annual earnings per share is currently -216.91% lower than the consensus analysts' forecast

EPS 1-year change

-2809.18%
SY annual earnings per share is down -2809.18% year-on-year

EPS Sector rank

61.11%
SY annual earnings per share is higher than 61.11% of companies in Healthcare sector

Profit

Gross profit

$125.30M
SY annual gross profit is $125.30 million

Gross margin

61.30%
SY annual gross profit margin is 61.30%

Operating profit

-$11.77M
SY annual operating income is -$11.77 million

Operating margin

-5.76%
SY annual operating profit margin is -5.76%

Net income

-$82.16M
SY annual net profit is -$82.16 million

Net margin

-40.19%
SY annual net profit margin is -40.19%

Expenses

Total expenses

$216.18M
SY annual total expenses is $216.18 million

Operating expenses

$137.08M
SY annual total operating expenses is $137.08 million

Cost of goods sold

$79.10M
SY annual cost of goods sold is $79.10 million

Selling, general & administrative expenses

$114.08M
SY annual SGA is $114.08 million

Depreciation and amortization

-
SY annual depreciation & amortization value is unknown

Interest expense

-
SY annual interest expense value is unknown

Income tax

-$126.10K
SY annual income tax is -$126.10 thousand

EBIT & EBITDA

EBIT

-$11.77M
SY annual earnings before interest & taxes is -$11.77 million

EBITDA

-$11.77M
SY annual EBITDA is -$11.77 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$374.67M
SY annual total assets is $374.67 million

Non current assets

$138.46M
SY annual long term assets is $138.46 million

Current assets

$236.21M
SY annual total current assets is $236.21 million

Cash and cash equivalents

$80.51M
SY annual cash & cash equivalents is $80.51 million

Accounts receivable

$13.53M
SY annual accounts receivable is $13.53 million

Inventory

$20.79M
SY annual inventory is $20.79 million

Liabilities

Total liabilities

$106.36M
SY annual total liabilities is $106.36 million

Long term liabilities

$20.03M
SY annual total long term liabilities is $20.03 million

Current liabilities

$86.33M
SY annual total current liabilities is $86.33 million

Accounts payable

-
SY annual accounts payable value is unknown

Debt

Total debt

$32.86M
SY annual total debt is $32.86 million

Total debt 1-year change

+59.79%
SY annual total debt is up +59.79% year-on-year

Long term debt

$17.15M
SY annual long term debt is $17.15 million

Short term debt

$15.71M
SY annual short term debt is $15.71 million

Equity & Capital

Shareholders equity

$251.93M
SY annual stockholders equity is $251.93 million

Book value

$251.93M
SY annual book value is $251.93 million

Retained earnings

-$126.90M
SY annual retained earnings is -$126.90 million

Working capital

$149.88M
SY annual working capital is $149.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
SY annual cash flow from operations value is unknown

Cash from operations 1-year change

-
SY annual cash flow from operations 1-year change is unknown

Cash from investing

-
SY annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
SY annual cash flow from investing activities 1-year change is unknown

Cash from financing

-
SY annual cash flow from financing activities value is unknown

Cash from financing 1-year change

-
SY annual cash flow from financing activities 1-year change is unknown

CAPEX

CAPEX

-
SY annual capital expenditures value is unknown

CAPEX 1-year change

-
SY annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-
SY annual free cash flow value is unknown

Free cash flow 1-year change

-
SY annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.30%
SY annual gross profit margin is 61.30%

Operating margin

-5.76%
SY annual operating profit margin is -5.76%

Net margin

-40.19%
SY annual net profit margin is -40.19%

ROA & ROE

ROA

-19.84%
SY annual return on assets is -19.84%

ROE

-26.10%
SY annual return on equity is -26.10%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SY price to earnings ratio value is unknown

PE ratio Sector rank

-
SY price to earnings ratio is unknown

PB Ratio

PB ratio

0.30
SY price to book ratio is 0.30

PB ratio Sector rank

23.77%
SY price to book ratio is higher than 23.77% of companies in Healthcare sector

PS Ratio

PS ratio

0.38
SY price to sales ratio is 0.38

PS ratio Sector rank

12.82%
SY price to sales ratio is higher than 12.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$29.18M
SY enterprise value is $29.18 million

Enterprise value Sector rank

35.59%
SY enterprise value is higher than 35.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.48
SY EV/EBITDA is -2.48

EV/EBITDA Sector rank

28.32%
SY EV/EBITDA is higher than 28.32% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.74
SY annual current ratio is 2.74

Quick ratio

2.50
SY annual quick ratio is 2.50

Leverage

Debt to equity

0.04
SY annual debt to equity ratio is 0.04

Interest coverage ratio

-
SY annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SY piotroski f-score value is unknown

Altman Z-Score

0.88
SY altman z-score is 0.88

Analyst ratings

Recent major analysts updates

Sep 23, 24 Citigroup
Neutral
Mar 23, 23 Jefferies
Buy
Mar 22, 23 Citigroup
Buy
Nov 26, 21 Needham
Buy
Mar 23, 21 Needham
Buy
Mar 23, 21 Canaccord Genuity
Buy
Aug 28, 20 Needham
Buy
May 19, 20 Canaccord Genuity
Buy
Mar 24, 20 Needham
Buy
Jun 10, 19 CICC
Buy

Institutional Ownership

Similar stocks

ENTX logo
Entera Bio (ENTX)
Whitehawk Therapeutics (WHWK)
FONR logo
FONAR (FONR)
AVTE logo
Aerovate Therapeutics (AVTE)
SRZN logo
Surrozen (SRZN)
BDSX logo
Biodesix (BDSX)
XGN logo
Exagen (XGN)
MBOT logo
Microbot Medical (MBOT)
SRTS logo
Sensus Healthcare (SRTS)
  • What is the ticker symbol for So-Young International?
  • Does So-Young International pay dividends?
  • What sector is So-Young International in?
  • What industry is So-Young International in?
  • What country is So-Young International based in?
  • When did So-Young International go public?
  • Is So-Young International in the S&P 500?
  • Is So-Young International in the NASDAQ 100?
  • Is So-Young International in the Dow Jones?
  • When was So-Young International's last earnings report?
  • When does So-Young International report earnings?

What is the ticker symbol for So-Young International?

The ticker symbol for So-Young International is NASDAQ:SY

Does So-Young International pay dividends?

Yes, So-Young International pays dividends. The last payment was $0.03, with an ex-dividend date on April 8, 2025

What sector is So-Young International in?

So-Young International is in the Healthcare sector

What industry is So-Young International in?

So-Young International is in the Health Information Services industry

What country is So-Young International based in?

So-Young International is headquartered in China

When did So-Young International go public?

So-Young International's initial public offering (IPO) was on May 2, 2019

Is So-Young International in the S&P 500?

No, So-Young International is not included in the S&P 500 index

Is So-Young International in the NASDAQ 100?

No, So-Young International is not included in the NASDAQ 100 index

Is So-Young International in the Dow Jones?

No, So-Young International is not included in the Dow Jones index

When was So-Young International's last earnings report?

So-Young International's most recent earnings report was on Mar 28, 2025

When does So-Young International report earnings?

The next expected earnings date for So-Young International is May 28, 2025
On this page